Retinoic Acid Used In Cancer Treatment

April 13, 1998

ITHACA, N.Y. -- A common chemical derivative of vegetables has been used by Cornell University researchers studying leukemia to block the uncontrolled cell division that leads to cancer.

The chemical is retinoic acid, a product of vitamin A, which the body manufactures from carotenes, the compounds found in a wide assortment of yellow-orange vegetables and fruits, from carrots and sweet potatoes to pumpkins and apricots.

Retinoic acid reverses the growth-promoting effects of oncogenes, the mutated genetic material that induces cancer, says Andrew Yen, a professor of pathology and director of one of the Cancer Biology Laboratories in Cornell University's College of Veterinary Medicine.

The finding, which to date has been restricted to the test-tube level, could lead to enhanced therapies for those cancers, including leukemia, that seem to respond to retinoic acid. The research also highlights the cancer-prevention role of carotenes.

"This is one more reason," Yen says, "to listen to your mother and eat your vegetables."

Yen reported the cell growth-arresting function of retinoic acid March 30 in New Orleans at the annual meeting of the American Association for Cancer Research. More details are in an article prepared for the association's journal, Cancer Research. Previously, progress by Yen's laboratory in explaining the role of retinoic acid was reported in a series of articles in several journals, including Blood, European Journal of Cell Biology and Experimental Cell Research.

Retinoic acid is a metabolic product of retinol, the active form of vitamin A. The compound had been shown by other researchers to regulate normal cell growth and differentiation. Yen's latest results -- using transforming proteins to switch on proto-oncogenes, the precursors to oncogenes -- demonstrate how retinoic acid can use the same chemical-signalling cascades that cause cell growth instead to arrest growth.

"Retinoic acid can reverse the defect in growth control that was caused by the viral agent and result in cell-growth arrest," Yen says, describing his experiments with cell cultures. "Now we need a deeper understanding of how retinoic acid causes these changes -- and exactly which molecules are affected by retinoic acid. In my dreams there is a single effector, but it's more likely there are several."

Ongoing studies in the Yen laboratory, supported in part by the National Cancer Institute and the U.S. Department of Agriculture's Program in Human Nutrition, aim to explain exactly how retinoic acid works on oncogenes and whether other, related compounds would be more effective in chemotherapy. As a result, oncologists might be able to fine-tune the chemotherapy cocktails given not only to leukemia patients but also to patients with other types of cancer, Yen suggests.

"In the meantime," he says, "I think we're adding evidence that an adequate supply of carotene in the diet is obviously beneficial for anyone who wishes to stay healthy and avoid cancer."
-end-


Cornell University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.